Re-Connect Application for Smoking Cessation

Part of paid clinical trials in Glassboro, New Jersey.

Sponsor
Rowan University
Study ID
NCT05224154
Status
Recruiting

Conditions

  • Acceptability of Health Care
  • Nicotine Dependence, Cigarettes
  • Smoking Cessation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Abstinent Contingent (AC) Re-Connect — BEHAVIORAL
    Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).
  • Submission Contingent (SC) Re-Connect — BEHAVIORAL
    Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Study Details

This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.

Key Dates

Start date
Dec 14, 2021
Status verified
Feb 2025
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026

Study Design

Enrollment
82 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Experimental: Abstinent Contingent (AC) Re-Connect
    Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO\<=6ppm).
  • Active Comparator: Submission Contingent (SC) Re-Connect
    Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence.

Primary Outcome Measure

System Usability Survey [ Time Frame: through study completion, up to 12-weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rowan UniversityGlassboroNew Jersey08028
Bethany Raiff, PhD
856-256-4500
Bethany Raiff, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Glassboro, NJ

Related Studies